Prognosis of Atypical Pituitary Adenomas

Status Active, not recruiting

Clinical Trial Summary

Context: Pituitary adenoma is generally indolent, but an aggressive subtype called atypical adenoma has uncertain prognosis, and an unclear relationship between prognosis and morphology.

Objective: This study investigated the prognostic factors of this tumor. Design: Retrospective analysis. Setting: University and associated hospitals.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Pituitary Diseases

Clinical Trial Details

NCT number	NCT00473369
Study type	Observational
Source	Tohoku University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 2001
Completion date	May 2007

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04897802` - Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)	Phase 4
Completed	`NCT03137615` - The Cardiovascular Changes Associated With Septal Local Anaesthesia	N/A
Completed	`NCT03305016` - A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency	Phase 3
Completed	`NCT02084134` - Peri-Operative Steroid Management in Patients	N/A
Completed	`NCT00234533` - Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq	Phase 3
Completed	`NCT04902235` - Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)	Phase 4
Recruiting	`NCT04951557` - Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas
Active, not recruiting	`NCT03665064` - Long Term Outcome Study in Patients With Pituitary Disorders
Completed	`NCT02782208` - Lipolytic Effects of GH in Hypopituitary Patients in Vivo	N/A
Recruiting	`NCT04326374` - Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency	Phase 3
Completed	`NCT03344458` - A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial	Phase 3
Completed	`NCT02781727` - A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)	Phase 3